| MAPPX | RGEBX | MAPPX / RGEBX | |
| Total Expense Ratio | 1.20 | 1.08 | 111% |
| Annual Report Gross Expense Ratio | 1.29 | 1.08 | 119% |
| Fund Existence | 16 years | 11 years | - |
| Gain YTD | -10.960 | -1.057 | 1,037% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 225M | 336B | 0% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -3.35 | 1.80 | -186% |
| Returns for 3 years | 72.05 | 41.63 | 173% |
| Returns for 5 years | -45.39 | 9.88 | -459% |
| Returns for 10 years | 57.86 | 110.02 | 53% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VSCAX | 28.51 | 0.20 | +0.71% |
| Invesco Small Cap Value A | |||
| HDRVX | 19.15 | 0.04 | +0.21% |
| Janus Henderson International Div N | |||
| LYFAX | 16.15 | 0.02 | +0.12% |
| AlphaCentric Life Sciences & Hlthcare A | |||
| FHOFX | 29.46 | N/A | N/A |
| Fidelity Series Large Cp Grwth Idx | |||
| BPSIX | 27.27 | -0.24 | -0.87% |
| Boston Partners Small Cap Value II I | |||